In addition, PKM2 in nucleus has been suggested as a novel modulator of genomic instability, cancer stemness, and cancer-associated inflammation, etc. [21–23] Therefore, reduction of nuclear PKM2 could be prioritized as a therapeutic strategy in anticancer research. The gene discussed is PKM; the disease is cancer.